- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06224933
Augmented Reality For MRI-Guided Interventions
January 24, 2024 updated by: Karun Sharma MD, Children's National Research Institute
Augmented Reality Real-Time Guidance for MRI-Guided Interventions
The purpose of this study is to determine feasibility and safety of using an augmented reality system in patients undergoing MRI-Guided needle procedures.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This pilot clinical study is designed to evaluate the feasibility of using a needle guidance system during MRI-guided procedures in up to 12 patients.
The MRI-compatible needle guidance system was developed under an NIH funded SBIR Phase II grant.
This system has been evaluated by our Interventional Radiology team in phantom, volunteer, and cadaver studies which showed potential benefit of use in patients.
Inclusion of the needle guidance system will not change the standard of care or substantively affect procedural technique as currently performed.
This system provides the operator with an augmented reality (AR) display to better visualize the needle entry point and trajectory as it is inserted toward the target.
This additional information could improve needle placement accuracy and shorten procedural time.
Study Type
Interventional
Enrollment (Estimated)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emily Leibold, BSE
- Phone Number: 202-476-5522
- Email: eleibold@childrensnational.org
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Recruiting
- Children's National Hospital
-
Contact:
- Karun Sharma, MD, PhD
- Phone Number: 202-476-3791
- Email: kvsharma@childrensnational.org
-
Contact:
- Emily Leibold, BSE
- Phone Number: 202-476-5522
- Email: eleibold@childrensnational.org
-
Principal Investigator:
- Karun Sharma, MD/PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, ages 3 to 21
- Patient referred to Interventional Radiology for image-guided needle injection, aspiration, or biopsy.
Exclusion Criteria:
- Patients who are unable to give informed consent themselves or through their parents.
- Patients under 3 years of age
- Patients over 300 pounds.
- Patients who are claustrophobic and unable to tolerate MRI-guided procedure.
- Contraindications to MRI such as MR-unsafe implants.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients Undergoing Augmented Reality Image-Guided Needle Procedures
Patients will undergo their standard of care image-guided needle biopsy, aspiration, or injection with the Augmented Reality system.
Patients will be monitored for adverse events for two weeks following their procedure.
|
Subjects will undergo image guided needle aspiration, injection, or biopsy facilitated by the Augmented Reality system.
The Augmented Reality guidance system will be operated by the interventional radiologist in the MRI suite.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Feasibility is measured by successful completion of greater than 80% of cases using the augmented reality needle guidance system.
Time Frame: 1 day
|
1 day
|
Safety of using the augmented reality needle guidance system will be evaluated through assessment of procedure related adverse events that occur within 7 days of the procedure.
Time Frame: 7 days
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Procedure time
Time Frame: 1 day
|
Total procedure time.
|
1 day
|
Number of MRI scans
Time Frame: 1 day
|
Number of MRI scans needed to complete the procedure, and size and depth of target will be recorded.
|
1 day
|
Clinical impressions of the system use and utility
Time Frame: 1 Day
|
The operator will complete a usability form that captures ease of use using the Likert scale.
|
1 Day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Karun Sharma, MD, PhD, Children's National Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 20, 2024
Primary Completion (Estimated)
January 1, 2026
Study Completion (Estimated)
January 1, 2026
Study Registration Dates
First Submitted
November 22, 2023
First Submitted That Met QC Criteria
January 24, 2024
First Posted (Actual)
January 25, 2024
Study Record Updates
Last Update Posted (Actual)
January 25, 2024
Last Update Submitted That Met QC Criteria
January 24, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00000648
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infections
-
International Centre for Diarrhoeal Disease Research...Centers for Disease Control and PreventionNot yet recruitingMeasles | Rubella | Cholera | Typhoid
-
MJM BontenJanssen Research & Development, LLC; Innovative Medicines InitiativeCompletedE.Coli InfectionsUnited States, United Kingdom, Canada, France, Germany, Italy, Japan, Spain
-
PfizerCompletedGroup B Streptococcus InfectionsUnited States, South Africa, United Kingdom
-
GlaxoSmithKlineActive, not recruitingInfections, MeningococcalFinland, Poland, Spain, United Kingdom, Germany, South Africa, Dominican Republic, Israel, Honduras
-
PfizerCompletedInfections, MeningococcalAustralia, Canada, Czechia, Panama, South Africa, Turkey
-
GlaxoSmithKlineCompletedInfections, MeningococcalFinland
-
PfizerCompletedInfections, MeningococcalPhilippines
-
GlaxoSmithKlineCompletedInfections, MeningococcalUnited States, Finland, Poland
-
GlaxoSmithKlineCompleted
Clinical Trials on Augmented Reality System
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Guangzhou Institute of Respiratory DiseaseShanghai Chest Hospital; Hong Kong Sanatorium & HospitalNot yet recruiting
-
University of PittsburghNortheastern University; NSFRecruiting
-
Chinese University of Hong KongNot yet recruiting
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedCentral Line ComplicationCanada
-
Stanford UniversityCompletedAcute Pain | Mobility Limitation | Spinal FusionUnited States
-
Brigham and Women's HospitalWithdrawnPain | Infection | MalignancyUnited States
-
Wayne State UniversityEnrolling by invitationSpecific Phobia, AnimalUnited States
-
University of VirginiaRecruitingPain, Acute | Vocal Cord Paralysis | Laryngeal Neoplasms | Vocal Fold PolypUnited States
-
Universidad Peruana Cayetano HerediaCompletedHospitalized ChildPeru